Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: A pilot randomized controlled study

Journal of Gastroenterology

Volumn 46, Issue 7, 2011, Pages 894-905

  Endo, Hiroki ^a   Higurashi, Takuma ^b   Hosono, Kunihiro ^a   Sakai, Eiji ^a   Sekino, Yusuke ^a   Iida, Hiroshi ^a   Sakamoto, Yasunari ^a   Koide, Tomoko ^a   Takahashi, Hirokazu ^a   Yoneda, Masato ^a   Tokoro, Chikako ^a   Inamori, Masahiko ^a   Abe, Yasunobu ^a   Nakajima, Atsushi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b YOKOHAMA ROSAI HOSPITAL   (Japan)

Author keywords

Capsule endoscopy; Low dose aspirin; Probiotics; Small bowel

Indexed keywords

ACETYLSALICYLIC ACID; BIOLACTIS; HEMOGLOBIN; OMEPRAZOLE; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

AGED; ARTICLE; CAPSULE ENDOSCOPY; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEMALE; HUMAN; INTESTINE INJURY; IRON DEFICIENCY ANEMIA; LACTOBACILLUS CASEI; LOW DRUG DOSE; MALE; MUCOSA INFLAMMATION; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SMALL INTESTINE DISEASE;

AGED; AGED, 80 AND OVER; ANEMIA, IRON-DEFICIENCY; ANTI-ULCER AGENTS; ASPIRIN; CAPSULE ENDOSCOPY; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INTESTINAL DISEASES; INTESTINAL MUCOSA; INTESTINE, SMALL; LACTOBACILLUS CASEI; MALE; MIDDLE AGED; OMEPRAZOLE; PILOT PROJECTS; PROBIOTICS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79960307847     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-011-0410-1     Document Type: Article

References (42)

1. EH Awtry J Loscalzo 2000 Aspirin Circulation 101 1206 1218 10715270 1:CAS:528:DC%2BD3cXit1aksL0%3D (Pubitemid 30146625)
2. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
3. C Patrono LA García Rodríguez R Landolfi C Baigent 2005 Low-dose aspirin for the prevention of atherothrombosis N Engl J Med 353 2373 2383 16319386 10.1056/NEJMra052717 1:CAS:528:DC%2BD2MXht1OmsbnM (Pubitemid 41713749)
4. J Weil D Colin-Jones M Langman D Lawson R Logan M Murphy, et al. 1995 Prophylactic aspirin and risk of peptic ulcer bleeding BMJ 310 827 830 7711618 1:STN:280:DyaK2M3islSntg%3D%3D
5. C Patrono 1994 Aspirin as an antiplatelet drug N Engl J Med 330 1287 1294 8145785 10.1056/NEJM199405053301808 1:CAS:528:DyaK2cXmt1Sks7w%3D (Pubitemid 24129964)
6. G Iddan G Meron A Glukhovsky P Swain 2000 Wireless capsule endoscopy Nature 405 417 10839527 10.1038/35013140 1:CAS:528:DC%2BD3cXjslyms70%3D
7. H Yamamoto Y Sekine Y Sato T Higashiwaza T Miyata S Iino, et al. 2001 Total enteroscopy with a nonsurgical steerable double-balloon method Gastrointest Endosc 53 216 220 11174299 10.1067/mge.2001.112181 1:STN:280:DC%2BD3Mzjslyisg%3D%3D (Pubitemid 32147608)
8. H Endo K Hosono M Inamori S Kato Y Nozaki K Yoneda, et al. 2009 Incidence of small bowel injury induced by low-dose aspirin: a crossover study using capsule endoscopy in healthy volunteers Digestion 79 44 51 19246922 10.1159/000204465 1:CAS:528:DC%2BD1MXjslWmt7g%3D
9. H Endo K Hosono M Inamori Y Nozaki K Yoneda K Fujita, et al. 2009 Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy J Gastroenterol 44 544 549 19373431 10.1007/s00535-009-0040-z 1:CAS:528: DC%2BD1MXntVKlurk%3D
10. T Matsumoto T Kudo M Esaki T Yano H Yamamoto C Sakamoto, et al. 2008 Prevalence of non-steroidal anti-inflammatory drug-induced enteropathy determined by double-balloon endoscopy: a Japanese multicenter study Scand J Gastroenterol 43 490 496 18365915 10.1080/00365520701794121 1:CAS:528: DC%2BD1cXjs12ktbc%3D (Pubitemid 351450993)
11. DY Graham JL Smith 1986 Aspirin and the stomach Ann Intern Med 104 390 398 3511824 1:STN:280:DyaL287ivVKmuw%3D%3D (Pubitemid 16163622)
12. T Watanabe K Higuchi A Kobata H Nichio T Tanigawa M Shiba, et al. 2008 Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent Gut 57 181 187 17639086 10.1136/gut.2007.125963 1:CAS:528:DC%2BD1cXisVyjsLw%3D (Pubitemid 351158044)
13. R Fuller 1991 Probiotics in human medicine Gut 32 439 442 1902810 10.1136/gut.32.4.439 1:STN:280:DyaK3M3isVGhsg%3D%3D
14. BJ Rembacken AM Snelling PM Hawkey DM Chalmers AT Axon 1999 Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial Lancet 354 635 639 10466665 10.1016/S0140-6736(98)06343-0 1:STN:280:DyaK1MzpsVGnsw%3D%3D (Pubitemid 29391428)
15. A Sood V Midha GK Makharia V Ahuja D Singal P Goswami, et al. 2009 The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis Clin Gastroenterol Hepatol 7 1202 1209 19631292 10.1016/j.cgh.2009.07.016
16. T Asahara K Nomoto M Watanuki T Yokokura 2001 Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection Antimicrob Agents Chemother 45 1751 1760 11353622 10.1128/AAC.45.6.1751-1760.2001 1:CAS:528:DC%2BD3MXjslyqsL0%3D (Pubitemid 32466345)
17. D Sgouras P Maragkoudakis K Petraki B Martinez-Gonzalez E Eriotou S Michopoulos, et al. 2004 In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota Appl Environ Microbiol 70 518 526 14711683 10.1128/AEM.70.1.518-526.2004 1:CAS:528:DC%2BD2cXmvFaltg%3D%3D (Pubitemid 38090245)
18. YW Chung JH Choi TY Oh CS Eun DS Han 2008 Lactobacillus casei prevents the development of dextran sulphate sodium-induced colitis in Toll-like receptor 4 mutant mice Clin Exp Immunol 151 182 189 18005362 10.1111/j.1365-2249.2007. 03549.x 1:CAS:528:DC%2BD1cXislCgt7s%3D (Pubitemid 350230997)
19. T Watanabe H Nishio T Tanigawa H Yamagami H Okazaki K Watanabe, et al. 2009 Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid Am J Physiol Gastrointest Liver Physiol 297 G506 G513 19589943 10.1152/ajpgi.90553.2008 1:CAS:528:DC%2BD1MXht1ykurnF
20. M Montalto A Gallo V Curigliano F D'Onofrio L Santoro M Covino, et al. 2010 Clinical trial: the effects of a probiotic mixture on non-steroidal anti-inflammatory drug enteropathy-a randomized, double-blind, cross-over, placebo-controlled study Aliment Pharmacol Ther 32 209 214 20384610 10.1111/j.1365-2036.2010.04324.x 1:CAS:528:DC%2BC3cXpslWlsLk%3D
21. S Fujimori T Seo K Gudis A Ehara T Kobayashi K Mitsui, et al. 2009 Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy Gastrointest Endosc 69 1339 1346 19243767 10.1016/j.gie.2008. 08.017
22. IM Gralnek R Defranchis E Seidman JA Leighton P Legnani BS Lewis 2008 Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change Aliment Pharmacol Ther 27 146 154 17956598 10.1111/j.1365-2036.2007.03556.x 1:STN:280:DC%2BD1c%2FgsFSnsg%3D%3D (Pubitemid 350256605)
23. H Endo K Hosono T Higurashi E Sakai H Iida Y Sakamoto, et al. 2011 Quantitative of low-dose aspirin-associated small bowel injury using a capsule endoscopy scoring index Dig Endosc 23 56 61 21198918 10.1111/j.1443-1661.2010. 01044.x
24. NM Davies F Jamali 1997 Pharmacological protection of NSAID-induced intestinal permeability in the rat: effect of tempo and metronidazole as potential free radical scavengers Hum Exp Toxicol 16 345 349 9257157 10.1177/096032719701600701 1:CAS:528:DyaK2sXls1Wlt7g%3D (Pubitemid 27371241)
25. AK Banerjee TJ Peters 1990 Experimental non-steroidal anti-inflammatory drug-induced enteropathy in the rat: similarities to inflammatory bowel disease and effect of thromboxane synthetase inhibitors Gut 31 1358 1364 1979954 10.1136/gut.31.12.1358 1:CAS:528:DyaK3MXlslChtL8%3D
26. H Koga K Aoyagi T Matsumoto M Iida M Fujishima 1999 Experimental enteropathy in athymic and euthymic rats: synergistic role of lipopolysaccharide and indomethacin Am J Physiol 276 G576 G582 10070032 1:CAS:528: DyaK1MXit1Wjsbc%3D
27. I Bjarnason J Hayllar P Smethurst A Price MJ Gumpel 1992 Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy Gut 33 1204 1208 1427372 10.1136/gut.33.9.1204 1:STN:280:DyaK3s%2FltFKlsg%3D%3D
28. TH Kent RM Cardelli FW Stamler 1969 Small intestinal ulcers and intestinal flora in rats given indomethacin Am J Pathol 54 237 249 5765565 1:STN:280:DyaF1M7hsVSntg%3D%3D
29. C Scarpignato 2008 NSAID-induced intestinal damage: are luminal bacteria the therapeutic target? Gut 57 145 148 18192448 10.1136/gut.2007.134502 1:CAS:528:DC%2BD1cXisVyjsL4%3D (Pubitemid 351158035)
30. P Hütt J Shchepetova K Lõivukene T Kullisaar M Mikelsaar 2006 Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens J Appl Microbiol 100 1324 1332 16696680 10.1111/j.1365-2672.2006.02857.x (Pubitemid 43725697)
31. S Matsumoto T Hara T Hori K Mitsuyama M Nagaoka N Tomiyasu, et al. 2005 Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells Clin Exp Immunol 140 417 426 15932502 10.1111/j.1365-2249.2005.02790.x 1:CAS:528:DC%2BD2MXlvFOis7c%3D (Pubitemid 40813951)
32. I Ingrassia A Leplingard A Darfeuille-Michaud 2005 Lactobacillus casei DN-114001 inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn's disease patients to adhere to and to invade intestinal epithelial cells Appl Environ Microbiol 71 2880 2887 15932981 10.1128/AEM.71.6.2880-2887. 2005 1:CAS:528:DC%2BD2MXlt1OktrY%3D (Pubitemid 40807190)
33. V Bertrand R Guimbaud M Tulliez C Mauprivez P Sogni D Couturier, et al. 1998 Increased in tumor necrosis factor-alpha production linked to the toxicity of indomethacin for the rat small intestine Br J Pharmacol 124 1385 1394 9723949 10.1038/sj.bjp.0701968 1:CAS:528:DyaK1cXlsVWntbY%3D (Pubitemid 28360560)
34. B Saud J Nandi G Ong S Finocchiaro RA Levine 2005 Inhibition of TNF-alpha improves indomethacin-induced enteropathy in rats by modulating iNOS expression Dig Dis Sci 50 1677 1683 16133968 10.1007/s10620-005-2914-0 1:CAS:528:DC%2BD2MXovVKksLk%3D (Pubitemid 41203661)
35. N Borruel M Carol F Casellas M Antolín F de Lara E Espín, et al. 2002 Increased mucosal tumor necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria Gut 51 659 664 12377803 10.1136/gut.51.5.659 1:CAS:528:DC%2BD38Xoslensrg%3D (Pubitemid 35216852)
36. A Van Gossum O Dewit E Louis G de Hertogh F Baert F Fontaine, et al. 2007 Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo-caecal resection Inflamm Bowel Dis 12 135 142 10.1002/ibd.20063 (Pubitemid 46806221)
37. J Kuisma S Mentula H Jarvinen A Kahri M Saxelin M Farkkila 2003 Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora Aliment Pharmacol Ther 17 509 515 12622759 10.1046/j.1365-2036.2003.01465.x 1:STN:280:DC%2BD3s7mslahsA%3D%3D (Pubitemid 36384810)
38. JL Goldstein GM Eisen B Lewis IM Gralnek S Zlotnick JG Fort, et al. 2005 Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo Clin Gastroenterol Hepatol 3 133 141 15704047 10.1016/S1542-3565(04)00619-6 (Pubitemid 40220308)
39. JL Goldstein GM Eisen B Lewis IM Gralnek J Aisenberg P Bhadra, et al. 2007 Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy Aliment Pharmacol Ther 15 1211 1222 10.1111/j.1365-2036.2007.03312.x (Pubitemid 46650300)
40. I Bjarnason P Smethurst CG Fenn CE Lee IS Menzies AJ Levi 1989 Misoprostol reduces indomethacin-induced changes in human small intestinal permeability Dig Dis Sci 34 407 411 2493366 10.1007/BF01536263 1:CAS:528:DyaL1MXhvVGmtbo%3D (Pubitemid 19088782)
41. T Watanabe S Sugimori N Kameda H Machida H Okazaki T Tanigawa, et al. 2008 Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study Clin Gastroenterol Hepatol 6 1279 1282 18995219 10.1016/j.cgh.2008.06.021
42. S Fujimori K Gudis Y Takahashi T Seo Y Yamada A Ehara, et al. 2010 Distribution of small intestinal mucosal injuries as a result of NSAID administration Eur J Clin Invest 40 504 510 20412292 10.1111/j.1365-2362.2010. 02290.x 1:CAS:528:DC%2BC3cXovVCltL4%3D